Spot-mas 360 Premium is a comprehensive screening test that combines Spot-mas multi-cancer detection with genetic risk assessment for 32 inherited cancer types, as well as risk of stroke and sudden cardiac death. It analyzes genes linked to hereditary cancers, blood cholesterol disorders, and cardiovascular diseases to support early detection, prevention, and personalized health management.
3-4 weeks upon receipt of sample in lab.